Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) E10: ¥-0.13 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600381 Qinghai Spring Medicinal Resources Technology Co Ltd SHSE:600381
64 GF Score
Price ¥4.20
GF Value ¥5.85
Valuation Modestly Undervalued
View Full Analysis

What is Qinghai Spring Medicinal Resources Technology Co E10?

Qinghai Spring Medicinal Resources Technology Co SHSE:600381 -1.64% 64 E10 is ¥-0.13 as of Mar. 2026. GuruFocus rates SHSE:600381 with a GF Score™ of 64/100 and a GF Value™ of ¥5.85 (Modestly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Qinghai Spring Medicinal Resources Technology Co's adjusted earnings per share data for the three months ended in Mar. 2026 was ¥-0.029. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥-0.13 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Qinghai Spring Medicinal Resources Technology Co was 57.70% per year. The lowest was -41.80% per year. And the median was -6.25% per year.

As of today (2026-07-19), Qinghai Spring Medicinal Resources Technology Co's current stock price is ¥4.20. Qinghai Spring Medicinal Resources Technology Co's E10 for the quarter that ended in Mar. 2026 was ¥-0.13. Qinghai Spring Medicinal Resources Technology Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Qinghai Spring Medicinal Resources Technology Co was 174.00. The lowest was 37.53. And the median was 67.53.


Qinghai Spring Medicinal Resources Technology Co  (SHSE:600381) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Qinghai Spring Medicinal Resources Technology Co was 174.00. The lowest was 37.53. And the median was 67.53.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Qinghai Spring Medicinal Resources Technology Co E10 Related Terms


Qinghai Spring Medicinal Resources Technology Co E10 Historical Data

* Premium members only.

The historical data trend for Qinghai Spring Medicinal Resources Technology Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qinghai Spring Medicinal Resources Technology Co E10 Chart

Qinghai Spring Medicinal Resources Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.66 0.15 0.07 -0.05 -0.12

Qinghai Spring Medicinal Resources Technology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.06 -0.08 -0.12 -0.13

SHSE:600381 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Qinghai Spring Medicinal Resources Technology Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qinghai Spring Medicinal Resources Technology Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qinghai Spring Medicinal Resources Technology Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Qinghai Spring Medicinal Resources Technology Co's Shiller PE Ratio falls into.


SHSE:600381
64GF Score
Qinghai Spring Medicinal Resources Technology Co Ltd SHSE:600381
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qinghai Spring Medicinal Resources Technology Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Qinghai Spring Medicinal Resources Technology Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.029/116.3033*116.3033
=-0.029

Current CPI (Mar. 2026) = 116.3033.

Qinghai Spring Medicinal Resources Technology Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.046 101.400 0.053
201609 0.049 102.400 0.056
201612 0.262 102.600 0.297
201703 0.055 103.200 0.062
201706 0.068 103.100 0.077
201709 0.157 104.100 0.175
201712 0.250 104.500 0.278
201803 0.069 105.300 0.076
201806 0.062 104.900 0.069
201809 -0.029 106.600 -0.032
201812 0.016 106.500 0.017
201903 0.013 107.700 0.014
201906 -0.008 107.700 -0.009
201909 -0.053 109.800 -0.056
201912 0.058 111.200 0.061
202003 -0.030 112.300 -0.031
202006 -0.080 110.400 -0.084
202009 -0.066 111.700 -0.069
202012 -0.364 111.500 -0.380
202103 -0.015 112.662 -0.015
202106 -0.070 111.769 -0.073
202109 -0.017 112.215 -0.018
202112 -0.318 113.108 -0.327
202203 -0.040 114.335 -0.041
202206 -0.043 114.558 -0.044
202209 -0.045 115.339 -0.045
202212 -0.362 115.116 -0.366
202303 -0.049 115.116 -0.050
202306 -0.037 114.558 -0.038
202309 -0.034 115.339 -0.034
202312 -0.340 114.781 -0.345
202403 -0.046 115.227 -0.046
202406 -0.056 114.781 -0.057
202409 -0.053 115.785 -0.053
202412 -0.185 114.893 -0.187
202503 0.016 115.116 0.016
202506 -0.014 114.907 -0.014
202509 -0.007 115.471 -0.007
202512 -0.065 115.832 -0.065
202603 -0.029 116.303 -0.029

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥-0.13 mean?
Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) has a E10 of ¥-0.13 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Qinghai Spring Medicinal Resources Technology Co and its competitors.
Is Qinghai Spring Medicinal Resources Technology Co's E10 too high?
Qinghai Spring Medicinal Resources Technology Co's current E10 is ¥-0.13. Overall, Qinghai Spring Medicinal Resources Technology Co has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qinghai Spring Medicinal Resources Technology Co's E10 compare to ZTS and UTHR?
Qinghai Spring Medicinal Resources Technology Co's E10 of ¥-0.13 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Qinghai Spring Medicinal Resources Technology Co and its competitors. Qinghai Spring Medicinal Resources Technology Co's current E10 is ¥-0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qinghai Spring Medicinal Resources Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.85, compared to a current price of ¥4.20 — trading 28.2% below its estimated fair value. The current E10 is ¥-0.13. Qinghai Spring Medicinal Resources Technology Co's overall GF Score™ is 64/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Qinghai Spring Medicinal Resources Technology Co (SHSE:600381), the current E10 is ¥-0.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) Overvalued in 2026?

Based on GuruFocus' analysis, Qinghai Spring Medicinal Resources Technology Co stock appears to be undervalued. The current stock price of ¥4.20 is trading 28.2% below its estimated GF Value™ of ¥5.85. GuruFocus considers Qinghai Spring Medicinal Resources Technology Co to be Modestly Undervalued.

Key valuation signals for SHSE:600381:

  • E10: ¥-0.13
  • GF Value™: ¥5.85 vs. price of ¥4.20 (28.2% below fair value)
  • GF Score™: 64/100

No single metric tells the full story. See the SHSE:600381 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Qinghai Spring Medicinal Resources Technology Co Business Description

Address East New Road 1, Xining Economic and Technological Development Zone, Xining, CHN, 810007
Qinghai Spring Medicinal Resources Technology Co Ltd is a China-based company that principally engaged in the integrated development, utilization, production, sales, and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company's main products are the cordyceps sinensis series products under the Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis, and raw cordyceps sinensis.
64GF Score

Get the complete analysis for SHSE:600381

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.20
Price
¥5.85
GF Value